MaxCyte (LON:MXCT) Shares Pass Below 50-Day Moving Average – Should You Sell?
by Michael Walen · The Markets DailyMaxCyte, Inc. (LON:MXCT – Get Free Report) shares crossed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of GBX 1.16 and traded as low as GBX 0.74. MaxCyte shares last traded at GBX 0.79, with a volume of 1,083,973 shares trading hands.
MaxCyte Trading Down 0.4%
The company has a current ratio of 9.81, a quick ratio of 14.38 and a debt-to-equity ratio of 8.59. The business has a 50 day simple moving average of GBX 1.16 and a two-hundred day simple moving average of GBX 1.40. The stock has a market cap of £842,684.39, a price-to-earnings ratio of -0.02 and a beta of 1.13.
About MaxCyte
MaxCyte is a leading cell-engineering company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and to support innovative, cell-based research. MaxCyte brings best-in-class technology paired with ongoing support designed to facilitate complex engineering of a wide variety of cells and payloads, with the aim of advancing new treatment options for patients. For over 20 years, MaxCyte has been perfecting the art of cell-engineering, venturing beyond today’s process to innovate tomorrow’s solutions.